DUBLIN, Nov. 22 (Xinhua) -- A vaccine production joint venture with a total investment of 240 million U.S. dollars will be built by a China-based company in Dundalk, a town in northeast Ireland, announced a senior Irish official here on Friday.
Heather Humphreys, Irish Minister for Business, Enterprise and Innovation, said in a press release that the planning application for the project, which is being supported by the Irish government, has been submitted to the local authorities.
The project, namely WuXi Vaccines, is expected to create 200 jobs over five years, she said, adding that this new project is the second investment in Dundalk by WuXi Biologics, a biologics manufacturing company based in Wuxi City, east China's Jiangsu Province.
In April 2018, WuXi Biologics announced a 325-million-euro (about 358 million U.S. dollars) investment to build a biologics production facility in Dundalk, which is wholly funded by the company itself. The project, called WuXi Biologics Ireland, is currently under construction and will be in commercial operation in 2022, said the press release.
The new WuXi Vaccines project is a joint venture between WuXi Biologics and Hile Bio-pharmaceutical, a global vaccine leader, and will be built on the same campus of WuXi Biologics Ireland, according to the press release. (1 euro = 1.102 U.S. dollars)
